Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

[1]  Sterling C. Johnson,et al.  Insulin resistance is associated with lower arterial blood flow and reduced cortical perfusion in cognitively asymptomatic middle-aged adults , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  J. Detre,et al.  Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study , 2017, Alzheimer disease and associated disorders.

[3]  Bryan J. Neth,et al.  Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial , 2017, Journal of Alzheimer's disease : JAD.

[4]  S. Agarwal,et al.  Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders. , 2017, Biochemical and biophysical research communications.

[5]  Matthias Gralle.  The neuronal insulin receptor in its environment , 2017, Journal of neurochemistry.

[6]  S. Allan,et al.  Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer’s Disease , 2016, Journal of Alzheimer's disease : JAD.

[7]  C. Brayne,et al.  Metaflammasome components in the human brain: a role in dementia with Alzheimer's pathology? , 2016, Brain pathology.

[8]  C. Power,et al.  HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation , 2017, Journal of Neuroimmune Pharmacology.

[9]  T. Montine,et al.  Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes , 2016, Neurobiology of Aging.

[10]  E. McNay,et al.  Novel Roles for the Insulin-Regulated Glucose Transporter-4 in Hippocampally Dependent Memory , 2016, The Journal of Neuroscience.

[11]  J. Williamson,et al.  Adiposity is inversely associated with hippocampal volume in African Americans and European Americans with diabetes. , 2016, Journal of diabetes and its complications.

[12]  V. Routh,et al.  Brain GLUT4 Knockout Mice Have Impaired Glucose Tolerance, Decreased Insulin Sensitivity, and Impaired Hypoglycemic Counterregulation , 2016, Diabetes.

[13]  H. Gu,et al.  Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction , 2016, Brain Imaging and Behavior.

[14]  C. Hölscher,et al.  Incretin-based therapy for type 2 diabetes mellitus is promising for treating neurodegenerative diseases , 2016, Reviews in the neurosciences.

[15]  M. Sander,et al.  Mechanisms of β‐cell functional adaptation to changes in workload , 2016, Diabetes, obesity & metabolism.

[16]  F. Schmitt,et al.  Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology , 2016, Alzheimer's & Dementia.

[17]  Impaired fasting glucose is associated with increased regional cerebral amyloid , 2016, Neurobiology of Aging.

[18]  M. Ehrlich,et al.  Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels , 2016, Alzheimer's & Dementia.

[19]  D. Holtzman,et al.  Changes in insulin and insulin signaling in Alzheimer’s disease: cause or consequence? , 2016, The Journal of experimental medicine.

[20]  D. Tropea,et al.  The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity , 2016, Neuroscience.

[21]  J. Fadel,et al.  Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits , 2016, Current Opinion in Behavioral Sciences.

[22]  G. King,et al.  Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture , 2016, Diabetes.

[23]  P. D. Meyts.  The Insulin Receptor and Its Signal Transduction Network , 2016 .

[24]  N. Kimura.  Diabetes Mellitus Induces Alzheimer’s Disease Pathology: Histopathological Evidence from Animal Models , 2016, International journal of molecular sciences.

[25]  Á. Pascual-Leone,et al.  "White Paper" meeting summary and catalyst for future inquiry: Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction. , 2016, F1000Research.

[26]  D. Yoo,et al.  Chronic type 2 diabetes reduces the integrity of the blood-brain barrier by reducing tight junction proteins in the hippocampus , 2016, The Journal of veterinary medical science.

[27]  D. El-Lebedy,et al.  Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease , 2016, Cardiovascular Diabetology.

[28]  Sher Ali,et al.  Genes, Genetics, and Environment in Type 2 Diabetes: Implication in Personalized Medicine. , 2016, DNA and cell biology.

[29]  Derek K. Jones,et al.  White Matter Microstructure and Cognitive Function in Young Women With Polycystic Ovary Syndrome , 2015, Journal of Clinical Endocrinology and Metabolism.

[30]  D. Devanand,et al.  Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial. , 2016, Journal of Alzheimer's disease : JAD.

[31]  M. Woodward,et al.  Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia , 2015, Diabetes Care.

[32]  H. Rao,et al.  Blood Pressure is Associated With Cerebral Blood Flow Alterations in Patients With T2DM as Revealed by Perfusion Functional MRI , 2015, Medicine.

[33]  B. Stollery,et al.  Glucose improves object-location binding in visual-spatial working memory , 2015, Psychopharmacology.

[34]  V. Srikanth,et al.  Type 2 diabetes mellitus and biomarkers of neurodegeneration , 2015, Neurology.

[35]  L. Pantoni,et al.  Is type 2 diabetes related to leukoaraiosis? an updated review , 2015, Acta neurologica Scandinavica.

[36]  Sterling C. Johnson,et al.  Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. , 2015, JAMA neurology.

[37]  D. Walker,et al.  Insulin Modulates In Vitro Secretion of Cytokines and Cytotoxins by Human Glial Cells. , 2015, Current Alzheimer research.

[38]  P. Heath,et al.  Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors , 2015, Molecular Brain.

[39]  M. Boehnke,et al.  Recent advances in understanding the genetic architecture of type 2 diabetes. , 2015, Human molecular genetics.

[40]  C. DeCarli,et al.  Glucose indices are associated with cognitive and structural brain measures in young adults , 2015, Neurology.

[41]  H. Rao,et al.  Disrupted resting-state attentional networks in T2DM patients , 2015, Scientific Reports.

[42]  J. Schneider,et al.  Vascular contributions to cognitive impairment and dementia including Alzheimer's disease , 2015, Alzheimer's & Dementia.

[43]  D. Butterfield,et al.  Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD , 2015, Journal of neurochemistry.

[44]  J. Walsh,et al.  High-Fat Diet Induces Hepatic Insulin Resistance and Impairment of Synaptic Plasticity , 2015, PloS one.

[45]  W. Maetzler,et al.  The Brain Response to Peripheral Insulin Declines with Age: A Contribution of the Blood-Brain Barrier? , 2015, PloS one.

[46]  Sterling C. Johnson,et al.  Insulin resistance predicts brain amyloid deposition in late middle-aged adults , 2015, Alzheimer's & Dementia.

[47]  H. Rao,et al.  Insulin Resistance-Associated Interhemispheric Functional Connectivity Alterations in T2DM: A Resting-State fMRI Study , 2015, BioMed research international.

[48]  M. Diamond,et al.  Plasma Lactate Levels Increase during Hyperinsulinemic Euglycemic Clamp and Oral Glucose Tolerance Test , 2015, Journal of diabetes research.

[49]  Jian Wang,et al.  Memory Dysfunction in Type 2 Diabetes Mellitus Correlates with Reduced Hippocampal CA1 and Subiculum Volumes , 2015, Chinese medical journal.

[50]  K. Ishii,et al.  Identification of diabetes-related dementia: Longitudinal perfusion SPECT and amyloid PET studies , 2015, Journal of the Neurological Sciences.

[51]  Dimitrios Kapogiannis,et al.  Insulin Resistance Predicts Medial Temporal Hypermetabolism in Mild Cognitive Impairment Conversion to Alzheimer Disease , 2015, Diabetes.

[52]  A. Goate,et al.  Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis , 2015, Biological Psychiatry.

[53]  Emily H. Trittschuh,et al.  Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. , 2015, Journal of Alzheimer's disease : JAD.

[54]  J. Freiherr,et al.  Central insulin administration improves odor-cued reactivation of spatial memory in young men. , 2015, The Journal of clinical endocrinology and metabolism.

[55]  Sterling C. Johnson,et al.  Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers. , 2015, Journal of Alzheimer's disease : JAD.

[56]  J. Schmeidler,et al.  Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms , 2014, European Neuropsychopharmacology.

[57]  M. Brundel,et al.  Brain imaging in type 2 diabetes , 2014, European Neuropsychopharmacology.

[58]  P. Kahle,et al.  Diet‐induced obesity accelerates the onset of terminal phenotypes in α‐synuclein transgenic mice , 2014, Journal of neurochemistry.

[59]  Richard D. Smith,et al.  Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. , 2014, Cell metabolism.

[60]  Jing Fang,et al.  Intranasal Insulin Enhanced Resting-State Functional Connectivity of Hippocampal Regions in Type 2 Diabetes , 2014, Diabetes.

[61]  C. Torborg,et al.  Recommendations of the Alzheimer's Disease–Related Dementias Conference , 2014, Neurology.

[62]  J. Trojanowski,et al.  Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies , 2014, Acta Neuropathologica.

[63]  I. Lucki,et al.  High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice , 2014, Neurobiology of Disease.

[64]  N. Cámpora,et al.  Cardiovascular risk factors and frontotemporal dementia: a case–control study , 2014, Translational Neurodegeneration.

[65]  S. Arnold,et al.  Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease , 2014, Diabetes.

[66]  C. Jack,et al.  Diabetes and Elevated Hemoglobin A1c Levels Are Associated with Brain Hypometabolism but Not Amyloid Accumulation , 2014, The Journal of Nuclear Medicine.

[67]  René Westerhausen,et al.  Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation , 2014, Human brain mapping.

[68]  Gwenn S. Smith,et al.  The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging , 2014, Psychiatry Research: Neuroimaging.

[69]  Cheng Hu,et al.  Genetics of Type 2 Diabetes: Insights into the Pathogenesis and Its Clinical Application , 2014, BioMed research international.

[70]  E. Benarroch.  Brain glucose transporters , 2014, Neurology.

[71]  Luca Cucullo,et al.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview. , 2014, Journal of pharmacovigilance.

[72]  Eric D. Vidoni,et al.  Impaired glycemia increases disease progression in mild cognitive impairment , 2014, Neurobiology of Aging.

[73]  P. Novak,et al.  Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes , 2014, Diabetes Care.

[74]  H. Preissl,et al.  Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans. , 2014, The Journal of clinical endocrinology and metabolism.

[75]  L. Rui,et al.  Energy metabolism in the liver. , 2014, Comprehensive Physiology.

[76]  Joan C. Borod,et al.  Neural substrates of verbal memory impairments in adults with type 2 diabetes mellitus , 2014, Journal of clinical and experimental neuropsychology.

[77]  L. Ación,et al.  Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: a cross-sectional study. , 2014, Journal of Alzheimer's disease : JAD.

[78]  J. Jurčovičová,et al.  Glucose transport in brain - effect of inflammation. , 2014, Endocrine regulations.

[79]  M. Synofzik,et al.  Evidence for altered transport of insulin across the blood–brain barrier in insulin-resistant humans , 2014, Acta Diabetologica.

[80]  C. Hölscher,et al.  New animal models of Alzheimer’s disease that display insulin desensitization in the brain , 2013, Reviews in the neurosciences.

[81]  J. Kielstein,et al.  Glucose levels and risk of dementia. , 2013, The New England journal of medicine.

[82]  T. Spires-Jones,et al.  Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice , 2013, Psychoneuroendocrinology.

[83]  F. Bai,et al.  Altered baseline brain activity in type 2 diabetes: A resting-state fMRI study , 2013, Psychoneuroendocrinology.

[84]  L. Ferrucci,et al.  Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging , 2013, Neurobiology of Aging.

[85]  L. Ferrucci,et al.  Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. , 2013, JAMA neurology.

[86]  S. Haneuse,et al.  Glucose levels and risk of dementia. , 2013, The New England journal of medicine.

[87]  Mark T. W. Ebbert,et al.  Genetics of Alzheimer's Disease , 2013, BioMed research international.

[88]  M. Sabbagh,et al.  Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status. , 2013, Current Alzheimer research.

[89]  R. Albin,et al.  Diabetes is associated with postural instability and gait difficulty in Parkinson disease. , 2013, Parkinsonism & related disorders.

[90]  A. Bhansali,et al.  Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies , 2013, Journal of diabetes investigation.

[91]  Sterling C. Johnson,et al.  Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults , 2013, Diabetes Care.

[92]  H. Arai,et al.  Brain accumulation of amyloid β protein visualized by positron emission tomography and BF‐227 in Alzheimer's disease patients with or without diabetes mellitus , 2013, Geriatrics & gerontology international.

[93]  F. D. De Felice.  Alzheimer's disease and insulin resistance: translating basic science into clinical applications. , 2013, The Journal of clinical investigation.

[94]  G. Eslick,et al.  Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. , 2013, Epidemiologic reviews.

[95]  James D. Johnson,et al.  Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. , 2012, Cell metabolism.

[96]  K. Kawabe,et al.  Clinical Features of Parkinson Disease when Onset of Diabetes Came First: A Case-Control Study , 2012, Neurology.

[97]  W. Banks,et al.  Insulin in the brain: there and back again. , 2012, Pharmacology & therapeutics.

[98]  A. Convit,et al.  Obesity and Metabolic Syndrome and Functional and Structural Brain Impairments in Adolescence , 2012, Pediatrics.

[99]  J. Cauley,et al.  Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. , 2012, Archives of neurology.

[100]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[101]  M. Shenton,et al.  Resting-State Brain Functional Connectivity Is Altered in Type 2 Diabetes , 2012, Diabetes.

[102]  Chih-Cheng Hsu,et al.  Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort. , 2012, Parkinsonism & related disorders.

[103]  Y. Reijmer,et al.  Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes. , 2012, Journal of diabetes and its complications.

[104]  R. Chaudhary,et al.  Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease , 2012, Cardiovascular Diabetology.

[105]  Domenico Consoli,et al.  Dementia is associated with Insulin Resistance in patients with Parkinson's Disease , 2012, Journal of the Neurological Sciences.

[106]  Chung-Yi Li,et al.  Risk of Parkinson Disease Onset in Patients With Diabetes , 2012, Diabetes Care.

[107]  D. Munoz,et al.  An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. , 2012, The Journal of clinical investigation.

[108]  J. Schneider,et al.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.

[109]  Samantha J. Brooks,et al.  Impaired Insulin Sensitivity as Indexed by the HOMA Score Is Associated With Deficits in Verbal Fluency and Temporal Lobe Gray Matter Volume in the Elderly , 2012, Diabetes Care.

[110]  T. Montine,et al.  Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .

[111]  A. Convit,et al.  Type 2 diabetes affects hippocampus volume differentially in men and women , 2012, Diabetes/metabolism research and reviews.

[112]  V. Haroutunian,et al.  Changes in glycemic control are associated with changes in cognition in non-diabetic elderly. , 2012, Journal of Alzheimer's disease : JAD.

[113]  S. M. de la Monte.  Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease. , 2012, Frontiers in bioscience.

[114]  A. Reiss,et al.  Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease , 2011, Neurobiology of Aging.

[115]  S. Kanba,et al.  Glucose tolerance status and risk of dementia in the community , 2011, Neurology.

[116]  K. Hsu,et al.  Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways , 2011, Neuropharmacology.

[117]  A. Saunders,et al.  Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies. , 2011, Current Alzheimer research.

[118]  Sudha Seshadri,et al.  Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults , 2011, Diabetes Care.

[119]  M. Heni,et al.  Insulin Promotes Glycogen Storage and Cell Proliferation in Primary Human Astrocytes , 2011, PloS one.

[120]  P. Lee,et al.  Mid-life and late-life vascular risk factors and dementia in Korean men and women. , 2011, Archives of gerontology and geriatrics.

[121]  Xuemei Huang,et al.  Diabetes and Risk of Parkinson’s Disease , 2011, Diabetes Care.

[122]  R. Zechner,et al.  Brain insulin controls adipose tissue lipolysis and lipogenesis. , 2011, Cell metabolism.

[123]  S. Minoshima,et al.  Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. , 2011, Archives of neurology.

[124]  J. Mielke,et al.  Insulin, synaptic function, and opportunities for neuroprotection. , 2011, Progress in molecular biology and translational science.

[125]  Hubert Preissl,et al.  Insulin Modulation of Magnetoencephalographic Resting State Dynamics in Lean and Obese Subjects , 2010, Front. Syst. Neurosci..

[126]  A. Hofman,et al.  Insulin metabolism and the risk of Alzheimer disease , 2010, Neurology.

[127]  Jan Born,et al.  Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory. , 2010, The Journal of clinical endocrinology and metabolism.

[128]  Rudolph E Tanzi,et al.  Diabetes-Associated SorCS1 Regulates Alzheimer's Amyloid-β Metabolism: Evidence for Involvement of SorL1 and the Retromer Complex , 2010, The Journal of Neuroscience.

[129]  B. Winblad,et al.  Diabetes, Alzheimer disease, and vascular dementia , 2010, Neurology.

[130]  J. Antel,et al.  Response of Human Oligodendrocyte Progenitors to Growth Factors and Axon Signals , 2010, Journal of neuropathology and experimental neurology.

[131]  K. Blennow,et al.  Cerebrospinal fluid insulin during non-neurological surgery , 2010, Journal of Neural Transmission.

[132]  B. A. Ardekani,et al.  Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus , 2010, Diabetologia.

[133]  Victoria E. Cotero,et al.  Mini-review: Impact of recurrent hypoglycemia on cognitive and brain function , 2010, Physiology & Behavior.

[134]  Jesús Avila,et al.  Role of glycogen synthase kinase-3 in Alzheimer’s disease pathogenesis and glycogen synthase kinase-3 inhibitors , 2010, Expert review of neurotherapeutics.

[135]  I. Torres-Aleman,et al.  Toward a comprehensive neurobiology of IGF‐I , 2010, Developmental neurobiology.

[136]  Hubert Preissl,et al.  Insulin modulates food-related activity in the central nervous system. , 2010, The Journal of clinical endocrinology and metabolism.

[137]  Rosemary O’Connor,et al.  Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling , 2010, Neurobiology of Aging.

[138]  J. Born,et al.  Euglycemic Infusion of Insulin Detemir Compared With Human Insulin Appears to Increase Direct Current Brain Potential Response and Reduces Food Intake While Inducing Similar Systemic Effects , 2010, Diabetes.

[139]  D. Clegg,et al.  Evaluation of the lack of anorectic effect of intracerebroventricular insulin in rats. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[140]  Suzanne Timmons,et al.  Akt signal transduction dysfunction in Parkinson's disease , 2009, Neuroscience Letters.

[141]  C. Grillo,et al.  Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent , 2009, Brain Research.

[142]  Charles D. Smith,et al.  Human cerebral neuropathology of Type 2 diabetes mellitus. , 2009, Biochimica et biophysica acta.

[143]  L. Kappelle,et al.  Cognition in the Early Stage of Type 2 Diabetes , 2009, Diabetes Care.

[144]  J. Henquin.  Regulation of insulin secretion: a matter of phase control and amplitude modulation , 2009, Diabetologia.

[145]  Stephan Züchner,et al.  Genomic convergence to identify candidate genes for Alzheimer Disease on chromosome 10 , 2009, Human mutation.

[146]  Paul K Crane,et al.  Different patterns of cerebral injury in dementia with or without diabetes. , 2009, Archives of neurology.

[147]  H. Soininen,et al.  β‐Amyloid deposition in brains of subjects with diabetes , 2009, Neuropathology and applied neurobiology.

[148]  S. M. de la Monte,et al.  Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. , 2009, Journal of Alzheimer's disease : JAD.

[149]  M. Arami,et al.  Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. , 2008, Diabetes research and clinical practice.

[150]  Sherita Hill Golden,et al.  Depression and Type 2 Diabetes Over the Lifespan , 2008, Diabetes Care.

[151]  B. Pakkenberg,et al.  Neocortical glial cell numbers in human brains , 2008, Neurobiology of Aging.

[152]  J. Buring,et al.  Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease , 2008, Diabetes Care.

[153]  V. Haroutunian,et al.  Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology , 2008, Neurology.

[154]  Nancy L. Pedersen,et al.  O1-05-08: Mid- and late-life diabetes in relation to the risk of dementia: A population-based twin study , 2008, Alzheimer's & Dementia.

[155]  Hollis T. Cline,et al.  Insulin Receptor Signaling Regulates Synapse Number, Dendritic Plasticity, and Circuit Function In Vivo , 2008, Neuron.

[156]  D. Alkon,et al.  Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. , 2008, European journal of pharmacology.

[157]  J. Born,et al.  Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. , 2008, The Journal of clinical endocrinology and metabolism.

[158]  Simon Lovestone,et al.  The GSK3 hypothesis of Alzheimer's disease , 2008, Journal of neurochemistry.

[159]  J. Born,et al.  Obese men respond to cognitive but not to catabolic brain insulin signaling , 2008, International Journal of Obesity.

[160]  G. Schellenberg,et al.  Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. , 2008, Journal of Alzheimer's disease : JAD.

[161]  H. Preissl,et al.  Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans , 2008, Diabetologia.

[162]  D. Leroith,et al.  Insulin and insulin-like growth factor receptors in the nervous system , 2008, Molecular Neurobiology.

[163]  B. Yandell,et al.  SORCS1: A Novel Human Type 2 Diabetes Susceptibility Gene Suggested by the Mouse , 2007, Diabetes.

[164]  G. Lienhard,et al.  Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane. , 2007, Cell metabolism.

[165]  Richard Mayeux,et al.  Relation of diabetes to mild cognitive impairment. , 2007, Archives of neurology.

[166]  G. Collingridge,et al.  LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β , 2007, Neuron.

[167]  A. Convit,et al.  Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes , 2007, Diabetologia.

[168]  D. Bennett,et al.  Diabetes is related to cerebral infarction but not to AD pathology in older persons , 2006, Neurology.

[169]  Y. T. Wang,et al.  Endogenous insulin signaling protects cultured neurons from oxygen–glucose deprivation-induced cell death , 2006, Neuroscience.

[170]  Geert Jan Biessels,et al.  Brain Imaging in Patients With Diabetes , 2006, Diabetes Care.

[171]  Paul K. Marsden,et al.  Attenuation of Insulin-Evoked Responses in Brain Networks Controlling Appetite and Reward in Insulin Resistance , 2006, Diabetes.

[172]  F. Kim,et al.  Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis , 2006, Brain Research.

[173]  N. Birbaumer,et al.  The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: A magnetoencephalographic study , 2006, Proceedings of the National Academy of Sciences.

[174]  G. Ramakers,et al.  Insulin signaling in the central nervous system: Learning to survive , 2006, Progress in Neurobiology.

[175]  D. Bennett,et al.  Diabetes mellitus, dementia, and cognitive function in older persons. , 2006, The Journal of Nutrition, Health & Aging.

[176]  P. Zandi,et al.  Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study , 2006, Alzheimer disease and associated disorders.

[177]  Jeroen van der Grond,et al.  Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. , 2006, Diabetes.

[178]  E. Uemura,et al.  Insulin regulates neuronal glucose uptake by promoting translocation of glucose transporter GLUT3 , 2006, Experimental Neurology.

[179]  G. Schellenberg,et al.  Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype , 2006, Neurobiology of Aging.

[180]  P. Scheltens,et al.  Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.

[181]  B. Winblad,et al.  Levels of mTOR and its downstream targets 4E‐BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain , 2005, The FEBS journal.

[182]  A. Artola,et al.  Insulin modulates hippocampal activity‐dependent synaptic plasticity in a N‐methyl‐d‐aspartate receptor and phosphatidyl‐inositol‐3‐kinase‐dependent manner , 2005, Journal of neurochemistry.

[183]  K. Nanjo,et al.  Subcellular localization of glucose transporter 4 in the hypothalamic arcuate nucleus of ob/ob mice under basal conditions , 2005, Brain Research.

[184]  Yu Wang,et al.  A biochemical and functional characterization of diet‐induced brain insulin resistance , 2005, Journal of neurochemistry.

[185]  Gary J. Schwartz,et al.  Hypothalamic KATP channels control hepatic glucose production , 2005, Nature.

[186]  R. Ravid,et al.  Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology , 2005, Journal of neurochemistry.

[187]  J. Wands,et al.  Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. , 2005, Journal of Alzheimer's disease : JAD.

[188]  J. Wands,et al.  Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? , 2005, Journal of Alzheimer's disease : JAD.

[189]  R. Nitsch,et al.  Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type , 2005, Journal of Neural Transmission.

[190]  Y. Han,et al.  Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt) , 2005, Journal of Neural Transmission.

[191]  A. Newman,et al.  The metabolic syndrome, inflammation, and risk of cognitive decline. , 2004, JAMA.

[192]  Jan Born,et al.  Intranasal insulin improves memory in humans , 2004, Psychoneuroendocrinology.

[193]  J. Born,et al.  Transcortical direct current potential shift reflects immediate signaling of systemic insulin to the human brain. , 2004, Diabetes.

[194]  E. Barrett-Connor,et al.  Diabetes, impaired fasting glucose, and development of cognitive impairment in older women , 2004, Neurology.

[195]  Bengt Winblad,et al.  Akt activity in Alzheimer's disease and other neurodegenerative disorders , 2004, Neuroreport.

[196]  B. McEwen,et al.  Glucose transporter expression in the central nervous system: relationship to synaptic function. , 2004, European journal of pharmacology.

[197]  William A Banks,et al.  The source of cerebral insulin. , 2004, European journal of pharmacology.

[198]  F. Grodstein,et al.  Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years , 2004, BMJ : British Medical Journal.

[199]  K. Hirayama,et al.  Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease , 1994, Acta Neuropathologica.

[200]  M. Permutt,et al.  Evaluation of rat insulin messenger RNA in pancreatic and extrapancreatic tissues , 1985, Diabetologia.

[201]  B. Wróblewska,et al.  The binding of insulin to cerebral capillaries and astrocytes of the rat , 1982, Neurochemical Research.

[202]  P. J. Koudstaal,et al.  Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI , 2003, Diabetologia.

[203]  Debashis Ghosh,et al.  Impact of diabetes on cognitive function among older Latinos: a population-based cohort study. , 2003, Journal of clinical epidemiology.

[204]  J. Meigs,et al.  The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. , 2003, Diabetes.

[205]  D. Ghosh,et al.  Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. , 2003, Annals of epidemiology.

[206]  S. Woods,et al.  Insulin and the blood-brain barrier. , 2003, Current pharmaceutical design.

[207]  D. Ghosh,et al.  Diabetes as a predictor of change in functional status among older Mexican Americans: a population-based cohort study. , 2003, Diabetes care.

[208]  Karen J. Ferguson,et al.  Increased blood–brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging , 2003, Journal of neurology, neurosurgery, and psychiatry.

[209]  H. Braak,et al.  Role of protein kinase B in Alzheimer's neurofibrillary pathology , 2003, Acta Neuropathologica.

[210]  P. E. Gold,et al.  Food for thought: fluctuations in brain extracellular glucose provide insight into the mechanisms of memory modulation. , 2002, Behavioral and cognitive neuroscience reviews.

[211]  L. Rossetti,et al.  Hypothalamic insulin signaling is required for inhibition of glucose production , 2002, Nature Medicine.

[212]  J. Bockmann,et al.  ProSAP/Shank postsynaptic density proteins interact with insulin receptor tyrosine kinase substrate IRSp53 , 2002, Journal of neurochemistry.

[213]  B. Goldstein.  Insulin resistance as the core defect in type 2 diabetes mellitus. , 2002, The American journal of cardiology.

[214]  G. Mcclearn,et al.  Diabetes Mellitus Is a Risk Factor for Vascular Dementia, but Not for Alzheimer's Disease: A Population-Based Study of the Oldest Old , 2002, International Psychogeriatrics.

[215]  K. Rockwood,et al.  Diabetes mellitus and the Risk of Dementia, Alzheimer’s Disease and Vascular Cognitive Impairment in the Canadian Study of Health and Aging , 2002, Dementia and Geriatric Cognitive Disorders.

[216]  P. Ye,et al.  Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-I (IGF-I) stimulation of brain growth and myelination. , 2002, Brain research. Developmental brain research.

[217]  Zhaohui Feng,et al.  Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats , 2002, Nature Neuroscience.

[218]  E. Air,et al.  Acute third ventricular administration of insulin decreases food intake in two paradigms , 2002, Pharmacology Biochemistry and Behavior.

[219]  R. Mayeux,et al.  The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function , 2002, Neurology.

[220]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[221]  H. Soininen,et al.  Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.

[222]  J. Manson,et al.  Type 2 diabetes and cognitive function in community-dwelling elderly women. , 2001, Diabetes care.

[223]  R. Duelli,et al.  Brain glucose transporters: relationship to local energy demand. , 2001, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[224]  B L Miller,et al.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.

[225]  P Ducimetière,et al.  Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. , 2001, Diabetes care.

[226]  R A Swanson,et al.  Astrocytic Glycogen Influences Axon Function and Survival during Glucose Deprivation in Central White Matter , 2000, The Journal of Neuroscience.

[227]  R. Martins,et al.  Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype , 2000, Annals of the New York Academy of Sciences.

[228]  P. E. Gold,et al.  Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[229]  D. Alkon,et al.  Brain Insulin Receptors and Spatial Memory , 1999, The Journal of Biological Chemistry.

[230]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[231]  R. Schliebs,et al.  Insulin‐sensitive GLUT4 glucose transporters are colocalized with GLUT3‐expressing cells and demonstrate a chemically distinct neuron‐specific localization in rat brain , 1999, Journal of neuroscience research.

[232]  M. Abbott,et al.  The Insulin Receptor Tyrosine Kinase Substrate p58/53 and the Insulin Receptor Are Components of CNS Synapses , 1999, The Journal of Neuroscience.

[233]  J. Born,et al.  Central nervous system effects of intranasally administered insulin during euglycemia in men. , 1999, Diabetes.

[234]  R. Stewart,et al.  Type 2 diabetes mellitus, cognitive impairment and dementia , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[235]  J. Unger,et al.  Insulin receptors and signal transduction proteins in the hypothalamo-hypophyseal system: a review on morphological findings and functional implications. , 1998, Histology and histopathology.

[236]  P. Magistretti,et al.  Evidence Supporting the Existence of an Activity-Dependent Astrocyte-Neuron Lactate Shuttle , 1998, Developmental Neuroscience.

[237]  K. Jellinger,et al.  Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease , 1998, Journal of Neural Transmission.

[238]  S. Hoyer,et al.  Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis , 1998, Journal of Neural Transmission.

[239]  W. Banks,et al.  Transport of Insulin Across the Blood-Brain Barrier: Saturability at Euglycemic Doses of Insulin , 1997, Peptides.

[240]  J. Heitner,et al.  Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects , 1997, Neurology.

[241]  I. Deary,et al.  Is Type II Diabetes Associated With an Increased Risk of Cognitive Dysfunction?: A critical review of published studies , 1997, Diabetes Care.

[242]  M. Laakso,et al.  Insulin Action and Age: European Group for the Study of Insulin Resistance (EGIR) , 1996, Diabetes.

[243]  Hiroshi Kimura,et al.  Insulin receptor mRNA in the substantia nigra in Parkinson's disease , 1996, Neuroscience Letters.

[244]  D. S. Zahm,et al.  Insulin gene expression and insulin synthesis in mammalian neuronal cells. , 1994, The Journal of biological chemistry.

[245]  S. Devaskar,et al.  Insulin II gene expression in rat central nervous system , 1993, Regulatory Peptides.

[246]  C Cobelli,et al.  Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. , 1993, The Journal of clinical investigation.

[247]  O. Madsen,et al.  Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[248]  R Sandyk,et al.  The relationship between diabetes mellitus and Parkinson's disease. , 1993, The International journal of neuroscience.

[249]  S. Woods,et al.  Insulin in the brain: a hormonal regulator of energy balance. , 1992, Endocrine reviews.

[250]  R. Schechter,et al.  Developmental regulation of insulin in the mammalian central nervous system , 1992, Brain Research.

[251]  L. Fisher,et al.  Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. , 1991, The Journal of clinical investigation.

[252]  J. Fleg,et al.  Age as Independent Determinant of Glucose Tolerance , 1991, Diabetes.

[253]  D. Porte,et al.  Localization of insulin receptor mRNA in rat brain by in situ hybridization. , 1990, Endocrinology.

[254]  K. O’Malley,et al.  Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. , 1990, Brain research. Molecular brain research.

[255]  G. Reaven,et al.  Relationship Between Hyperglycemia and Cognitive Function in Older NIDDM Patients , 1990, Diabetes Care.

[256]  G. Werther,et al.  Localization and Characterization of Insulin‐Like Growth Factor‐I Receptors in Rat Brain and Pituitary Gland Using in vitro Autoradiography and Computerized Densitometry * A Distinct Distribution from Insulin Receptors , 1989, Journal of neuroendocrinology.

[257]  P. R. Gilmore,et al.  Glucose transport in primary cultured neurons , 1989, Journal of neuroscience research.

[258]  G. Werther,et al.  Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. , 1987, Endocrinology.

[259]  D. Porte,et al.  Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. , 1987, The Journal of clinical endocrinology and metabolism.

[260]  M. Raizada,et al.  Insulin Is Released from Rat Brain Neuronal Cells in Culture , 1986, Journal of neurochemistry.

[261]  W. Young.  Periventricular hypothalamic cells in the rat brain contain insulin mRNA , 1986, Neuropeptides.

[262]  W. Pardridge,et al.  Human Blood—Brain Barrier Insulin Receptor , 1985, Journal of neurochemistry.

[263]  D. Singer,et al.  Decreased cognitive function in aging non-insulin-dependent diabetic patients. , 1984, The American journal of medicine.

[264]  M. Raizada,et al.  Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain. , 1984, The Journal of biological chemistry.

[265]  B. Winblad,et al.  Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. , 2009, Acta medica Scandinavica.

[266]  S. Woods,et al.  The role of insulin as a satiety factor in the central nervous system. , 1983, Advances in metabolic disorders.

[267]  B. Ajaya,et al.  Effects of insulin administered into cerebrospinal fluid spaces on blood glucose in unanaesthetized and anaesthetized dogs. , 1982, The Indian journal of medical research.

[268]  H. Bernstein,et al.  C-peptide immunoreactive neurons in human brain. , 1982, Acta histochemica.

[269]  Ralph A. DeFronzo.  Glucose Intolerance and Aging , 1981, Diabetes Care.

[270]  S. Woods,et al.  Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons , 1979, Nature.

[271]  J. Strubbe,et al.  Increased feeding in response to bilateral injection of insulin antibodies in the VMH , 1977, Physiology & Behavior.

[272]  W. Millard,et al.  Short-term influence of intra-ventromedial hypothalamic administration of insulin on feeding in normal and diabetic rats. , 1974, Pharmacology, biochemistry, and behavior.

[273]  S. Aronson.  INTRACRANIAL VASCULAR LESIONS IN PATIENTS WITH DIABETES MELLITUS , 1973, Journal of neuropathology and experimental neurology.

[274]  A. Debons,et al.  A direct action of insulin on the hypothalamic satiety center. , 1970, The American journal of physiology.

[275]  R. Snider.  The Human Brain in Figures and Tables , 1969, Neurology.

[276]  M. Rinkel,et al.  INSULIN TREATMENT IN PSYCHIATRY , 1959, The Ulster Medical Journal.

[277]  W. R. Miles,et al.  PSYCHOLOGIC TESTS APPLIED TO DIABETIC PATIENTS , 1922 .